Volume 15, Issue 57 (12-2024)                   NCMBJ 2024, 15(57): 43-56 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hasani Fard M, Olad G, Amani J. Design and Production of Aptamer Against CholeraToxin Using SELEX Technique. NCMBJ 2024; 15 (57) :43-56
URL: http://ncmbjpiau.ir/article-1-1717-en.html
Applied Biotechnology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. , jafar.amani@gmail.com
Abstract:   (175 Views)

Aim and Background: Diarrhea is the second main cause of mortality in the world that produced by vibrio cholera. Vibrio cholera is the important microorganism related with pandemic and epidemic cholera outbreaks. Detection in the early stage is considered to prevent the distribution of disease. Cholera toxin (CT) is the major virulence factor of disease.  Aptamers have emerged as highly efficient agents for the specific detection and binding of bacterial targets. These versatile molecules offer a promising alternative to antibodies, finding applications in biomarker discovery, diagnosis, imaging, and targeted therapy. They are produced by asymmetric PCR and selected through the Systematic Evolution of Ligands by Exponential Enrichment (SELEX).

 

 Material and Methods:  In this study, aptamers generated by asymmetric PCR were utilized, after running 11 rounds of SELEX, numerous aptamers were selected and evaluated using ELASA to check their binding to CtxB and similar proteins.

 

Results: Appropriate aptamers were isolated and sequenced. Then the best aptamer with the highest affinity to CtxB (amount of OD was 1.8) and the least cross-reactivity to similar proteins were separated. Bioinformatics studies for this aptamer show the proper interaction between the aptamer and the CtxB.

Conclusion: Selected aptamer has high affinity and specificity to CtxB. We assessed the effectiveness of this aptamer using ELASA. It can be used for diagnostic purposes.
Corresponding author:
Applied Biotechnology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Email:
jafar.amani@gmail.com

 
Full-Text [PDF 727 kb]   (42 Downloads)    
Type of Study: Research Article | Subject: Cellular and molecular
Received: 2025/02/23 | Accepted: 2024/12/21 | Published: 2024/12/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb